<DOC>
	<DOCNO>NCT01901861</DOCNO>
	<brief_summary>study hypothesis examine acute effect glycaemia islet hormone secretion increase level endogenous GLP-1 GIP islet cell function men type 2 diabetes . To purpose , standardize mixed meal test ingest without concomitant administration sitagliptin ( 100mg ) .</brief_summary>
	<brief_title>Effect DPP-4 Inhibitor Sitagliptin Islet Function After Mixed Meal Patients With Type 2 Diabetes</brief_title>
	<detailed_description>In men subject type 2 diabetes treat diet exercise without metformin treatment antidiabetic agent , standardize mixed meal test serve without administration sitagliptin ( 100mg ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Dipeptidyl-Peptidase IV Inhibitors</mesh_term>
	<criteria>Caucasian men type 2 diabetes diagnose accord ICD10 Ongoing treatment life style adjustment life style adjustment together metformin oral antidiabetic . Metformin therapy exceed 2 gram daily Age 2075 year HbA1c â‰¤80 mmol/mol BMI : 2040 kg/m2 Liver disease ALAT three time upper reference range Diabetic nephropathy ( GFR &lt; 50 mL/min/1.73 m2 albuminuria ) Proliferative diabetic retinopathy Treatment glucoselowering medication except metformin Previous myocardial infarction , coronary heart disease insatiable angina pectoris last 6 month . Previous surgery gastrointestinal tract Larger surgical intervention last 12 week Treatment oral steroid thiazide diuretic Treatment digoxin Smokers Participation another study last 4 week Paracetamol intolerance</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>GLP-1 , GIP , DPP-4 inhibition , iset function</keyword>
</DOC>